- CA$25.98m
- CA$26.44m
- CA$0.17m
Annual balance sheet for Diagnos, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.87 | 1.36 | 0.921 | 0.297 | 0.219 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.344 | 0.204 | 0.345 | 0.263 | 0.167 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.34 | 1.59 | 1.29 | 0.575 | 0.407 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.065 | 0.328 | 0.253 | 0.248 | 0.257 |
Long Term Investments | |||||
Total Assets | 2.43 | 1.95 | 1.54 | 0.823 | 0.664 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.581 | 0.55 | 0.659 | 0.719 | 1.62 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.615 | 0.818 | 1.66 | 2.77 | 3.72 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1.82 | 1.13 | -0.114 | -1.95 | -3.05 |
Total Liabilities & Shareholders' Equity | 2.43 | 1.95 | 1.54 | 0.823 | 0.664 |
Total Common Shares Outstanding |